{
    "clinical_study": {
        "@rank": "166560", 
        "acronym": "RX Registry", 
        "brief_summary": {
            "textblock": "This registry is designed to assess the clinically relevant benefits of balloon angioplasty\n      and stenting in superficial femoral and popliteal artery, using rapid exchange technology."
        }, 
        "brief_title": "Rapid Exchange Devices Observational Registry.", 
        "completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "condition": "Lower-extremity Peripheral Arterial Disease.", 
        "condition_browse": {
            "mesh_term": [
                "Peripheral Arterial Disease", 
                "Peripheral Vascular Diseases"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Patients with symptomatic one or two legs ischemia, requiring treatment of SFA or\n             popliteal artery\n\n          -  Rutherford classification 2-5\n\n          -  Single lesion with recoiling/dissection/restenosis after balloon angioplasty or de\n             novo lesions with stenosis or occlusion,\n\n          -  Target vessel reference diameter \u22654mm and \u22647mm (by visual estimate)\n\n          -  At least one patent (less than 50% stenosis) tibioperoneal run-off vessel confirmed\n             by baseline angiography\n\n          -  Patient is suitable candidate for femoral-popliteal artery bypass surgery\n\n        Exclusion Criteria:\n\n          -  Female of child-bearing potential.\n\n          -  Previous bypass surgery\n\n          -  In stent restenosis as a target lesion\n\n          -  Scheduled staged procedure of multiple lesions within the ipsilateral iliac or\n             popliteal arteries within 30 days after index procedure.\n\n          -  Co-existing aneurysmal disease of the abdominal aorta, iliac or popliteal arteries\n\n          -  Acute thrombophlebitis or deep venous thrombosis\n\n          -  Hemodynamic instability\n\n          -  Untreated inflow disease of the ipsilateral pelvic arteries (more than 50 percent\n             stenosis or occlusion),\n\n          -  Significant gastrointestinal bleeding or any coagulopathy that would contraindicate\n             the use of anti-platelet therapy\n\n          -  Known intolerance to study medications, contrast agents or nitinol."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "18 Years", 
            "sampling_method": "Non-Probability Sample", 
            "study_pop": {
                "textblock": "Patients with one lesion located in Superficial Femoral Artery(SFA) or popliteal artery\n        planned to be treated as per hospital practice with plain old balloon angioplasty and\n        nitinol stent using monorail (rapid exchange) delivery system."
            }
        }, 
        "enrollment": {
            "#text": "525", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "November 20, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01994798", 
            "org_study_id": "T122E2"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "February 17, 2014", 
        "location": [
            {
                "contact": {
                    "last_name": "Roel Beelen, Dr."
                }, 
                "facility": {
                    "address": {
                        "city": "Aalst", 
                        "country": "Belgium"
                    }, 
                    "name": "Onze-Lieve-Vrouwziekenhuis (OLV) Aalst"
                }, 
                "investigator": {
                    "last_name": "Roel Beelen, Dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Michiel Van Betsbrugge, Dr."
                }, 
                "facility": {
                    "address": {
                        "city": "Antwerp", 
                        "country": "Belgium"
                    }, 
                    "name": "GasthuisZusters Antwerpen (GZA) Ziekenhuizen"
                }, 
                "investigator": {
                    "last_name": "Michiel Van Betsbrugge, Dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Cezar Vazquez, Dr."
                }, 
                "facility": {
                    "address": {
                        "city": "Auvelais-Val de Sambre", 
                        "country": "Belgium"
                    }, 
                    "name": "Centre Hospitalier R\u00e9gional (CHR) du Val de Sambre"
                }, 
                "investigator": {
                    "last_name": "Cezar Vazquez, Dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Jean-Pierre Lacquet, Dr."
                }, 
                "facility": {
                    "address": {
                        "city": "Hasselt", 
                        "country": "Belgium"
                    }, 
                    "name": "Jessa Ziekenhuis"
                }, 
                "investigator": {
                    "last_name": "Jean-Pierre Lacquet, Dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Christophe Martinez, Dr."
                }, 
                "facility": {
                    "address": {
                        "city": "Li\u00e8ge", 
                        "country": "Belgium"
                    }, 
                    "name": "Centre Hospitalier Universitaire (CHU) Li\u00e8ge"
                }, 
                "investigator": {
                    "last_name": "Christophe Martinez, Dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Omar Andr\u00e9s Navarro, Dr."
                }, 
                "facility": {
                    "address": {
                        "city": "Girona", 
                        "country": "Spain"
                    }, 
                    "name": "Hospital Universitari Dr. Josep Trueta de Girona"
                }, 
                "investigator": {
                    "last_name": "Omar Andr\u00e9s Navarro, Dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }, 
            {
                "contact": {
                    "last_name": "Josua Van den Berg, Prof.Dr."
                }, 
                "facility": {
                    "address": {
                        "city": "Lugano", 
                        "country": "Switzerland"
                    }, 
                    "name": "Ospedale Regionale di Lugano"
                }, 
                "investigator": {
                    "last_name": "Josua Van den Berg, Prof.Dr.", 
                    "role": "Principal Investigator"
                }, 
                "status": "Not yet recruiting"
            }
        ], 
        "location_countries": {
            "country": [
                "Belgium", 
                "Spain", 
                "Switzerland"
            ]
        }, 
        "number_of_groups": "1", 
        "official_title": "Prospective, Non-randomized, Multicentre, Observational Registry to Assess Clinically Relevant Benefit of Performing the Whole PTA Procedure Using the Rapid Exchange (RX) Devices.", 
        "overall_contact": {
            "email": "dragica.paunovic@terumo-europe.com", 
            "last_name": "Dragica Paunovic, Dr."
        }, 
        "overall_official": [
            {
                "affiliation": "Centre Hospitalier Universitaire (CHU) Li\u00e8ge", 
                "last_name": "Christophe Martinez", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Hospital Universitari Dr. Josep Trueta de Girona", 
                "last_name": "Omar Andr\u00e9s Navarro", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Ospedale Regionale di Lugano", 
                "last_name": "Josua Van den Berg", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": [
                "Belgium: Ethics Committee", 
                "Switzerland: Ethikkommission", 
                "Spain: Comit\u00e9 \u00c9tico de Investigaci\u00f3n Cl\u00ednica"
            ], 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "October 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": [
            {
                "measure": "Safety: composite of all-cause death, amputation, TVR, stroke or bleeding (BARC \u2265 3) up to 1 month", 
                "safety_issue": "Yes", 
                "time_frame": "From start up to 30 Days post procedure."
            }, 
            {
                "measure": "Total contrast media volume given during the procedure.", 
                "safety_issue": "No", 
                "time_frame": "During procedure"
            }
        ], 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01994798"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": [
            {
                "measure": "Total duration of the procedure", 
                "safety_issue": "No", 
                "time_frame": "During procedure"
            }, 
            {
                "measure": "Total fluoroscopy time", 
                "safety_issue": "No", 
                "time_frame": "During procedure"
            }, 
            {
                "measure": "Total radiation dose given", 
                "safety_issue": "No", 
                "time_frame": "During procedure"
            }, 
            {
                "measure": "Technical success defined as a successful access and balloon angioplasty followed by stent placement with achieved recanalization determined by less than 30% residual stenosis by angiography at the baseline procedure.", 
                "safety_issue": "No", 
                "time_frame": "Pre- and post-procedure"
            }, 
            {
                "measure": "Clinical success defined as technically successful procedure without the events considered in safety composite endpoint (all-cause death, amputation, TVR, stroke or bleeding (BARC \u2265 3) up to 1 month.", 
                "safety_issue": "No", 
                "time_frame": "During procedure"
            }, 
            {
                "measure": "Total acute complication rate defined as any device- or procedure- related complication up to 1 month post procedure.", 
                "safety_issue": "Yes", 
                "time_frame": "Up to 30 Days post procedure"
            }, 
            {
                "measure": "Total acute device related complication rate defined as any device complication up to 1 month post procedure.", 
                "safety_issue": "Yes", 
                "time_frame": "Up to 30 Days post procedure"
            }, 
            {
                "measure": "Ankle-Brachial Index (ABI) improvement at 30 days.", 
                "safety_issue": "No", 
                "time_frame": "30 Days post procedure"
            }, 
            {
                "measure": "Improvement of the Rutherford index at 30 days.", 
                "safety_issue": "No", 
                "time_frame": "30Days post procedure"
            }, 
            {
                "measure": "Walking distance at 30 days compared with walking distance before procedure.", 
                "safety_issue": "No", 
                "time_frame": "30 Days post procedure"
            }, 
            {
                "measure": "Bleeding complication as per BARC definitions.", 
                "safety_issue": "Yes", 
                "time_frame": "Up to 30 days post procedure"
            }
        ], 
        "source": "Terumo Europe N.V.", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Terumo Europe N.V.", 
                "agency_class": "Industry"
            }
        }, 
        "start_date": "November 2013", 
        "study_design": "Observational Model: Case-Only, Time Perspective: Prospective", 
        "study_type": "Observational [Patient Registry]", 
        "target_duration": "30 Days", 
        "verification_date": "February 2014"
    }
}